Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, August 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 171 articles: HTML format

Single Articles

1. SAUER GM, Kas F, Mihai CM, Elhai M, et al
   Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis.
   Rheumatology (Oxford). 2025 Aug 1:keaf410. doi: 10.1093.
   PubMed    
   Abstract available
   
   

2. AMEEN H, Karim A, Anjum A
   Clinical insights on sacubitril/valsartan alters pulmonary arterial pressure in heart failure with maintained ejection fraction and pulmonary hypertension among PD patients.
   Int Urol Nephrol. 2025 Aug 1. doi: 10.1007/s11255-025-04686.
   PubMed    
   
   
   

3. COSTA-RODRIGUEZ N, Vera-Rodriguez DJ, Falcon-Cordon S, Morales BR, et al
   Pulmonary hypertension and NT-proBNP dynamics during the course of adulticide treatment in dogs naturally infected by Dirofilaria immitis.
   Parasit Vectors. 2025;18:313.
   PubMed    
   Abstract available
   
   

4. CAMERON JE, McElhinney DB, Liu E, Hopper RK, et al
   Pharmacologic Management of Segmental Pulmonary Hypertension in Children After Unifocalization and Pulmonary Artery Reconstruction: Initial Experience.
   Pulm Circ. 2025;15:e70134.
   PubMed    
   Abstract available
   
   

5. VOLLMERS K, Scandurra J, Woolley JR, Giridharan GA, et al
   Development of a Novel, Pulmonary Endovascular Device to Treat Patients With Pulmonary Hypertension.
   Pulm Circ. 2025;15:e70131.
   PubMed    
   Abstract available
   
   

6. MEHMOOD AM, Hassan SMS, Malik A, Faizan M, et al
   Rare Case of Laurence-Moon-Bardet-Biedl Syndrome With Pulmonary Hypertension: A Case Report.
   Clin Case Rep. 2025;13:e70691.
   PubMed    
   Abstract available
   
   

7. CHEN ZY, Cao Y, Yang J, He XH, et al
   Case Report: A case of severe pulmonary hypertension combined with FBN1 mutation associated geleophysic dysplasia.
   Front Pediatr. 2025;13:1642390.
   PubMed    
   Abstract available
   
   

8. ISOMATSU S, Takeda K, Shionoya Y, Sugiura T, et al
   A management of a patient with chronic thromboembolic pulmonary hypertension prior to surgical resection for lung cancer.
   Respir Med Case Rep. 2025;57:102269.
   PubMed    
   Abstract available
   
   

9. LEE SY, Jung HO, Kim KA, Oh GC, et al
   Impact of the New Definition on the Prognosis of Patients With Pulmonary Hypertension Compared to the Classic Definition.
   Korean Circ J. 2025 Jul 1. doi: 10.4070/kcj.2024.0416.
   PubMed    
   Abstract available
   
   

10. REISER AE, Thiersch M, Gassmann M, Muckenthaler MU, et al
    Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70142.
    PubMed    
    Abstract available
    
    

11. LIU PL, Xu ZW, Kuo WS, Hsu CH, et al
    Pulmonary artery hypertension-induced vascular structure analysis using label-free fluorescence lifetime imaging.
    Opt Express. 2025;33:31935-31948.
    PubMed    
    Abstract available
    
    

12. DODSON MW, Allen-Brady K, Stevens J, Cirulis MM, et al
    Rare variants in STAB2 in patients with chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2025;11:01322-2024.
    PubMed    
    Abstract available
    
    

13. MONTANI D, Toshner M
    The genetics of chronic thromboembolic pulmonary hypertension: no longer a stab in the dark.
    ERJ Open Res. 2025;11:00551-2025.
    PubMed    
    Abstract available
    
    

14. WREN JT JR, Shibbani K
    Sound Waves Versus Pressure Waves: The Increasing Role of Echocardiography and Noninvasive Vasoreactivity Testing in Pediatric Pulmonary Hypertension Management.
    Echocardiography. 2025;42:e70254.
    PubMed    
    
    
    

15. LIU J, Rong C, Wang Y, Wang B, et al
    Pulmonary hypertension associated with rheumatoid arthritis: A case report and causal association verification through Mendelian randomization.
    Medicine (Baltimore). 2025;104:e43116.
    PubMed    
    Abstract available
    
    

16. ASHUR A, Levy A, Liel-Cohen N, Sergienko R, et al
    Prognostic Value of Pulmonary Hypertension as an Incidental Finding Detected by Echocardiography in Patients Without Known Cardiovascular or Pulmonary Diseases.
    J Clin Med. 2025;14:5044.
    PubMed    
    Abstract available
    
    

17. CACIA M, Imbalzano E, Ciconte VA, Vatrano M, et al
    Pulmonary Hypertension: Let's Take Stock!
    Life (Basel). 2025;15:1137.
    PubMed    
    Abstract available
    
    

18. PARIKH R, Dagher C, Farber HW
    Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease.
    Life (Basel). 2025;15:1089.
    PubMed    
    Abstract available
    
    

19. COSTA-RODRIGUEZ N, Vera-Rodriguez DJ, Falcon-Cordon S, Morales BR, et al
    Urinary NGAL as an Early Marker of Renal Dysfunction in Dogs with Heartworm Disease and Pulmonary Hypertension.
    Animals (Basel). 2025;15:2003.
    PubMed    
    Abstract available
    
    

20. KIM S, Seo Y, Oh MY, Kim MS, et al
    Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia.
    Biomedicines. 2025;13:1725.
    PubMed    
    Abstract available
    
    

21. CARBONE RG, Puppo F, Thomas CA, Savarino V, et al
    Porto-Pulmonary Hypertension and Hepato-Pulmonary Syndrome: Diagnostic Procedures and Therapeutic Management.
    Diagnostics (Basel). 2025;15:1821.
    PubMed    
    Abstract available
    
    

22. GILLMEYER KR, Shusterman S, Rinne ST, Elwy AR, et al
    Gaps in access to pulmonary hypertension care and opportunities for improvement: a multi-site qualitative study.
    BMC Pulm Med. 2025;25:355.
    PubMed    
    Abstract available
    
    

23. QIN J, Wang G, Han D
    Erratum to "Selexipag in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" [Current Problems in Cardiology 48(2023) 101466].
    Curr Probl Cardiol. 2025 Jul 26:103127. doi: 10.1016/j.cpcardiol.2025.103127.
    PubMed    
    
    
    

24. ZHUO ML, Xu JL, Zhang W, Rao GW, et al
    Efficacy of sildenafil combined with statins in treating pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Pathol Res Pract. 2025;273:156097.
    PubMed    
    Abstract available
    
    

25. HERRERA E, Salamanca JF, Durango LF
    The role of agitated saline contrast echocardiography in the evaluation of pulmonary hypertension.
    Arch Peru Cardiol Cir Cardiovasc. 2025;6:90-95.
    PubMed    
    Abstract available
    
    

26. INGRAM J, Stubbs H, Lua S, Brewis M, et al
    Digital Inclusion in a Scottish National Pulmonary Hypertension Population.
    Pulm Circ. 2025;15:e70135.
    PubMed    
    Abstract available
    
    

27. DAGAN M, Nanayakkara S, Chan W, McGiffin DC, et al
    Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.
    EBioMedicine. 2025;118:105867.
    PubMed    
    Abstract available
    
    

28. SHI Y, Xu Y, Li Y, Yan C, et al
    ALKBH5 regulates ACSL4 to sensitize erastin-induced ferroptosis via YTHDF2-dependent m(6)A modification in hypoxic pulmonary hypertension.
    Free Radic Biol Med. 2025 Jul 24:S0891-5849(25)00848.
    PubMed    
    Abstract available
    
    

29. SHIMOKAWAHARA H, Nishizaki M, Inami T, Kubota K, et al
    Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial.
    Lancet Respir Med. 2025 Jul 23:S2213-2600(25)00127.
    PubMed    
    Abstract available
    
    

30. KAOUS M, Ryoo Ali HJ, Ok CY, Iliescu C, et al
    Relapse of Acute Myelogenous Leukemia With History of Myeloproliferative Neoplasm and Exacerbation of Pulmonary Hypertension.
    JACC Case Rep. 2025;30:104136.
    PubMed    
    Abstract available
    
    

31. KODESH A, Levie S, Garcia MJ
    Transthoracic Echocardiography in Diagnosing Mixed Pulmonary Hypertension in a Patient With Bioprosthetic Mitral Valve Replacement.
    JACC Case Rep. 2025;30:104146.
    PubMed    
    Abstract available
    
    

32. ALGHAMDI KS, Maiter A, Hyde GA, Alnasser T, et al
    Pulmonary Hypertension and the Role of MRI Flow Assessment: A Systematic Review.
    Br J Radiol. 2025 Jul 25:tqaf182. doi: 10.1093.
    PubMed    
    Abstract available
    
    

33. LEBAR K, Tantisuwat L, Pang J, Chicco AJ, et al
    Distinct Right Ventricular Performance in Response to Acute Colchicine Treatment in Healthy and Diseased States.
    Function (Oxf). 2025;6:zqaf021.
    PubMed    
    Abstract available
    
    

34. SABRY M, Wieslander B, Hermida U, Fernandes JF, et al
    Vortex duration in the pulmonary artery does not depend on vascular Afterload: a sign of adaptation?
    Comput Biol Med. 2025;196.
    PubMed    
    Abstract available
    
    

35. ALSUMALI A, McLaughlin V, Chevure J, Klok R, et al
    Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.
    Adv Ther. 2025;42:3902-3921.
    PubMed    
    Abstract available
    
    

36. KUWABARA Y, Yokokawa T, Lemay SE, Sauvaget M, et al
    Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension.
    Am J Pathol. 2025;195:1376-1393.
    PubMed    
    Abstract available
    
    

37. WATZKER A, Alsumali A, Ferro C, Li XJ, et al
    The Potential Impact of Sotatercept on Long-Term Disability in Commercially Insured Patients with Pulmonary Arterial Hypertension in the United States: An Exercise in Actuarial Modeling.
    Adv Ther. 2025;42:3678-3690.
    PubMed    
    Abstract available
    
    

38. KWAPISZEWSKA G, Rhodes C, Rabinovitch M, Simpson C, et al
    Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective.
    Am J Respir Cell Mol Biol. 2025;73:200-209.
    PubMed    
    Abstract available
    
    

39. HEATH A, von Alvensleben I, Spielvogel JA, Freudenthal P, et al
    Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia.
    Exp Physiol. 2025;110:1060-1070.
    PubMed    
    Abstract available
    
    

40. LEGCHENKO E, Chouvarine P, Hysko K, Qadri F, et al
    Inhalation of the Novel Tryptophan Hydroxylase 1 Inhibitor TPT-004 Alleviates Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2025;73:288-298.
    PubMed    
    Abstract available
    
    

41. ZHAO SS, Yuan C, Liu JL, Wu QC, et al
    SETD2 drives METTL14-mediated m(6)A to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension.
    Cell Mol Life Sci. 2025;82:302.
    PubMed    
    Abstract available
    
    

42. THAL BR, Rako ZA, Kremer NC, Yogeswaran A, et al
    Exercise haemodynamics in pulmonary hypertension - a prospective pressure-volume loop study on right ventricular adaptation and prognosis.
    Eur J Heart Fail. 2025 Aug 7. doi: 10.1002/ejhf.3802.
    PubMed    
    Abstract available
    
    

43. ZHANG T, Zhu L, Liu B, Liu J, et al
    Binding of Hypoxia-Induced Mitogenic Factor/RELM-beta to Bone Morphogenetic Protein Receptor 2 Complex Promotes Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2025 Aug 7. doi: 10.1161/ATVBAHA.125.322652.
    PubMed    
    Abstract available
    
    

44. MONTOYA L JP, Vasquez J, Uribe Gonzalez R, Guzman-Medina M, et al
    From Pulmonary Hyperlucency to Pulmonary Hypertension: A Case Report of Swyer-James-MacLeod Syndrome.
    Cureus. 2025;17:e87392.
    PubMed    
    Abstract available
    
    

45. FARBER HW
    My Introduction to Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70124.
    PubMed    
    
    
    

46. DEMONCHEAUX E
    Unraveling Nonenzymatic Nitric Oxide Production and Its Impact on Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70152.
    PubMed    
    
    
    

47. QI X, Jun L, Wang D, Zhou H, et al
    Right Ventricular Myocardial Global Longitudinal Strain Assessment of Right Ventricular Function in Patients with Pulmonary Embolism.
    Kardiologiia. 2025;65:46-54.
    PubMed    
    Abstract available
    
    

48. CHEN G, Zhang Z, Zhao X, Huang K, et al
    Maternal and neonatal outcomes in pregnancies complicated with pulmonary hypertension: a retrospective cohort study.
    Eur J Med Res. 2025;30:717.
    PubMed    
    Abstract available
    
    

49. YANAKA K, Nakayama K, Taniguchi Y, Onishi H, et al
    Difference in efficacy between pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    BMC Pulm Med. 2025;25:376.
    PubMed    
    Abstract available
    
    

50. ISHAAYA E, Yee N, DeCato TW
    Six-Minute Walk Testing: Performance, Properties, and Clinical Applications.
    Clin Chest Med. 2025;46:467-479.
    PubMed    
    Abstract available
    
    

51. BICHUETTE LD, Calderaro D, Lemos Neto PA, Fonseca EKUN, et al
    Left Main Coronary Artery Angioplasty for the Treatment of Extrinsic Compression in Patients with Pulmonary Hypertension.
    Arq Bras Cardiol. 2025;122:e20250002.
    PubMed    
    Abstract available
    
    

52. RICH S
    My Quest for Calcium Channel Blockers as the First Medical Treatment for Patients With Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70151.
    PubMed    
    
    
    

53. BUTROUS G
    The Emergence of Oral Sildenafil for Pulmonary Hypertension Management.
    Pulm Circ. 2025;15:e70150.
    PubMed    
    
    
    

54. SANDERS R, Walsh T, Baird G, Atalay M, et al
    Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.
    medRxiv [Preprint]. 2025 Aug 2:2025.08.01.25332627.
    PubMed    
    Abstract available
    
    

55. POYATOS P, Peinado VI, Blanco I, Osorio J, et al
    Assessing the role of endothelium-protective drugs: Functional and molecular insights into chronic thromboembolic pulmonary hypertension derived endothelial cells.
    Biomed Pharmacother. 2025;190:118425.
    PubMed    
    Abstract available
    
    

56. KAVANAGH T, Kilpatrick T, Hardy B, Lee S, et al
    Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
    Ann Card Anaesth. 2025 Aug 5. doi: 10.4103.
    PubMed    
    Abstract available
    
    

57. RANA SS, Dilshad RA, Nawaz S, Usman M, et al
    Impact of Systemic Sclerosis-Associated Interstitial Lung Disease, With and Without Pulmonary Hypertension, on Survival: A Systematic Review.
    Cureus. 2025;17:e87303.
    PubMed    
    Abstract available
    
    

58. MA R, Cui J, Zheng Y, Tao H, et al
    A nomogram model for predicting maternal cardiovascular complications and neonatal adverse outcomes in pregnant patients with pulmonary arterial hypertension.
    Ann Med. 2025;57:2541093.
    PubMed    
    Abstract available
    
    

59. OBA Y, Maduke T, Fakhouri EW, Goite Y, et al
    Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.
    Cochrane Database Syst Rev. 2025;8:CD015824.
    PubMed    
    Abstract available
    
    

60. KINTADA G, Prasad AK, Prasad AM, Agstam S, et al
    Ballooned Out the Clot-Rescue Balloon Pulmonary Angioplasty in a Young Male Presenting With Acute on Chronic Thromboembolic Pulmonary Hypertension.
    Catheter Cardiovasc Interv. 2025 Aug 4. doi: 10.1002/ccd.70067.
    PubMed    
    Abstract available
    
    

61. RODOLFI S, Ng CCM, Ruiz Bejerano AM, Kanitkar M, et al
    Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension.
    Clin Exp Rheumatol. 2025;43:1492-1498.
    PubMed    
    Abstract available
    
    

62. SUN L, Tian H, Liu J, Liu M, et al
    The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70118.
    PubMed    
    Abstract available
    
    

63. DING R, Xie H, Zhang Y, Qin L, et al
    Ginsenoside Rg1 Ameliorates Pulmonary Hypertension by Inhibiting cGAS/STING Mediated Cell Senescence.
    Drug Des Devel Ther. 2025;19:6487-6504.
    PubMed    
    Abstract available
    
    

64. KHURANA JK, Lipsitz S, Geisser DL, Moynihan KM, et al
    Neighborhood Child Opportunity Index and Outcomes in Pediatric Pulmonary Hypertension.
    Pediatr Cardiol. 2025 Aug 2. doi: 10.1007/s00246-025-03981.
    PubMed    
    Abstract available
    
    

65. SU R, Pritazahra A, Saverimuttu SC, Lovering R, et al
    MicroRNA regulation of PPARG Signalling: Therapeutic implications for pulmonary hypertension.
    Comput Biol Med. 2025;196.
    PubMed    
    Abstract available
    
    

66. ABUBAKER J, Shaikh AS, Hassan M, Ammar A, et al
    National Institute Pulmonary Hypertension Registry (NIPHeR): Insights from the first pulmonary hypertension registry of Pakistan.
    J Pak Med Assoc. 2025;75:1058-1066.
    PubMed    
    Abstract available
    
    

67. BELHAKIM M, El Jaouhahri Z, Boudar A, Benaddi L, et al
    Severe pertussis complicated by pulmonary hypertension in a Moroccan infant: a case report.
    J Med Case Rep. 2025;19:379.
    PubMed    
    Abstract available
    
    

68. ZOU Y, Ding Y
    Insights into gas exchange, pulmonary artery capacity, and postural variations in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    J Cardiol. 2025 Jul 30:S0914-5087(25)00194-7. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    

69. LI Y, Yang X, Zeng M, Luo T, et al
    Meta-analysis evaluating the risks and outcomes of pulmonary hypertension in pregnant women.
    Pregnancy Hypertens. 2025;41:101241.
    PubMed    
    Abstract available
    
    

70. WU W, Kong F, Chen Z, Huang L, et al
    Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2025;14:e042713.
    PubMed    
    Abstract available
    
    

71. WANG Y, Guo Z, Ma X, Xu Q, et al
    Integrated transcriptome and metabolome analysis reveals the therapeutic mechanism of Huang-Qi-Si-Wu-Tang in experimental pulmonary arterial hypertension.
    Phytomedicine. 2025;145:157058.
    PubMed    
    Abstract available
    
    

72. WU Q, Ye H, Zhou Z, Zhang M, et al
    Current landscape for connective tissue disease associated-pulmonary arterial hypertension: a focus on right ventricular adaptation and failure.
    Future Cardiol. 2025;21:803-814.
    PubMed    
    Abstract available
    
    

73. WANG X, Zhu Z, Jia H, Lu X, et al
    Critical role of mitochondrial dynamics in chronic respiratory diseases and new therapeutic directions.
    Chin Med J (Engl). 2025;138:1783-1793.
    PubMed    
    Abstract available
    
    

74. LI WH, Ma WJ, Zhang W, Zhao SN, et al
    Programmed Cell Death: A Pivotal Player in Pulmonary Arterial Hypertension.
    Eur J Pharmacol. 2025 Jul 8:177934. doi: 10.1016/j.ejphar.2025.177934.
    PubMed    
    Abstract available
    
    

75. MA WJ, Li WH, Zhao XM, Zhang W, et al
    Significance of ALDH3A2, a mitochondrial metabolism and glycolysis related gene, in pulmonary arterial hypertension.
    Eur J Pharmacol. 2025;1003:177923.
    PubMed    
    Abstract available
    
    

76. VERMA D, Estrada RA, Sahay S
    The role of imaging in risk assessment for pulmonary arterial hypertension.
    Curr Opin Cardiol. 2025;40:327-334.
    PubMed    
    Abstract available
    
    

77. CHEN M, Pang L, Huang T, Liang W, et al
    Integrating single-cell RNA-seq, bulk RNA-seq, and Mendelian randomization to elucidate the role of HLA-DPA1 expression levels and non-classical monocytes in the pathogenesis of idiopathic pulmonary arterial hypertension.
    Int J Biol Macromol. 2025;319.
    PubMed    
    Abstract available
    
    

78. HAJIPOUR M, Labarca G, Ayas N, Azarbarzin A, et al
    Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes.
    Semin Respir Crit Care Med. 2025;46:221-232.
    PubMed    
    Abstract available
    
    

79. PATEL K, Ananthanarayanan C, Gajjar T, Mishra A, et al
    Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months- A Single Center Experience.
    World J Pediatr Congenit Heart Surg. 2025;16:640-647.
    PubMed    
    Abstract available
    
    

80. NIELSEN CTH, Holm Nielsen S, Sondergaard Korsholm S, Diederichsen ACP, et al
    Fibroblast activities are associated with prolonged QTc and pulmonary arterial hypertension in patients with systemic sclerosis.
    Clin Exp Rheumatol. 2025;43:1439-1445.
    PubMed    
    Abstract available
    
    

81. JHAVERI V, Lakshminrusimha S, Singh Y
    Hemodynamics during noninvasive ventilation in neonates.
    Semin Perinatol. 2025;49:152065.
    PubMed    
    Abstract available
    
    

82. WANG Y, Yan B, Ma P, Zhou R, et al
    Mechanism of action of aloperine in the treatment of pulmonary arterial hypertension based on network pharmacology and molecular docking methods.
    Herz. 2025;50:287-294.
    PubMed    
    Abstract available
    
    

83. SMITH V, Marjenberg Z, Volkmann ER
    The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review.
    Clin Exp Rheumatol. 2025;43:1516-1526.
    PubMed    
    Abstract available
    
    

84. BYARD RW
    A forensic overview of deaths in mountainous terrain.
    Forensic Sci Med Pathol. 2025;21:952-956.
    PubMed    
    Abstract available
    
    

85. EL ISKANDARANI M, Golamari R, Bettinotti BGM, Akiki E, et al
    Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression.
    J Thorac Dis. 2025;17:5108-5121.
    PubMed    
    Abstract available
    
    

86. TRIPIPITSIRIWAT A, Malhotra A, Robertson H, Kim NH, et al
    The Role of Obstructive Sleep Apnea in Pulmonary Hypertension Associated with Lung Diseases (Group 3 Pulmonary Hypertension): A Narrative Review.
    J Clin Med. 2025;14:5442.
    PubMed    
    Abstract available
    
    

87. ITO K, Kato S, Yasuda N, Sawamura S, et al
    Integrating CT-Based Lung Fibrosis and MRI-Derived Right Ventricular Function for the Detection of Pulmonary Hypertension in Interstitial Lung Disease.
    J Clin Med. 2025;14:5329.
    PubMed    
    Abstract available
    
    

88. DING R, Xie H, Sang S, Qin L, et al
    Astragaloside IV alleviates hypoxic pulmonary hypertension by inhibiting RELM-beta to reduce PINK1/Parkin-mediated mitophagy in pulmonary artery smooth muscle cells (PASMCs).
    Br J Pharmacol. 2025 Aug 13. doi: 10.1111/bph.70166.
    PubMed    
    Abstract available
    
    

89. PALEVSKY HI
    The Genesis and Legacy of the NHLBI Patient Registry for the Characterization of Primary Pulmonary Hypertension (NIH-PPH Registry).
    Pulm Circ. 2025;15:e70148.
    PubMed    
    
    
    

90. ZHANG H, Shao F, Gao C, Tian L, et al
    Pulmonary Vascular Remodeling in Pulmonary Hypertension Mice Aggravated by Hypothyroidism.
    Endocrinology. 2025;166:bqaf122.
    PubMed    
    Abstract available
    
    

91. DRABIK L, Wasilewski G, Waligora M, Piatek J, et al
    Unloading left ventricle and unlocking transplant options: Impella 5.5 in advanced heart failure with pulmonary hypertension.
    Kardiol Pol. 2025 Aug 12. doi: 10.33963/v.phj.108032.
    PubMed    
    
    
    

92. SHIMA H, Tsujino I, Nakaya T, Nakamura J, et al
    Right Ventricular Dysfunction in Lung Disease/Hypoxia-Associated Pulmonary Hypertension.
    J Am Heart Assoc. 2025 Aug 12:e042186. doi: 10.1161/JAHA.125.042186.
    PubMed    
    Abstract available
    
    

93. ALTAMIMI T, Almahdi M, Algarni SS, Alshreedah S, et al
    Oxygenation indices and echocardiographic markers of pulmonary hypertension and ventricular dysfunction in congenital diaphragmatic hernia.
    BMJ Paediatr Open. 2025;9:e003637.
    PubMed    
    Abstract available
    
    

94. CAO X, Ma J, Chen K, Luo M, et al
    Wheat Grain Moxibustion as an Adjuvant Therapy for Chronic Fatigue in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    J Vis Exp. 2025;.
    PubMed    
    Abstract available
    
    

95. MA J, Cao X, Chen K, Dang K, et al
    Electroacupuncture as an Adjuvant Therapy for Dyspnea in Patients with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    J Vis Exp. 2025;.
    PubMed    
    Abstract available
    
    

96. DUAN J, Liu L, Guo S, Sun H, et al
    Evaluation of pulmonary perfusion and ventilation in suspected chronic thromboembolic pulmonary hypertension via phase-resolved functional lung magnetic resonance imaging: correlations with hemodynamics and cardiopulmonary function.
    Quant Imaging Med Surg. 2025;15:7169-7182.
    PubMed    
    Abstract available
    
    

97. SATO H, Takahashi Y, Hasegawa T, Someya Y, et al
    Feature-Tracking Method Can Estimate Right Ventricular Contractile Properties in Rats With Pulmonary Hypertension.
    Circ Rep. 2025;7:685-691.
    PubMed    
    Abstract available
    
    

98. YANG L, Hou W, Lan J, Liu R, et al
    Self-Assembled Tetrahedral Framework Nucleic Acids Alleviate Pulmonary Hypertension by Regulating Calcium Homeostasis.
    Adv Healthc Mater. 2025 Aug 11:e02810. doi: 10.1002/adhm.202502810.
    PubMed    
    Abstract available
    
    

99. CHO S, Farghaly MAA, Ramey S, Abdalla A, et al
    Pulmonary hypertension, inhaled nitric oxide, and retinopathy of prematurity: evidence from the U.S. national database.
    Pediatr Res. 2025 Aug 9. doi: 10.1038/s41390-025-04323.
    PubMed    
    Abstract available
    
    

100. ERMIS N, Ozhan O, Yildiz A, Ulutas Z, et al
     Comparison of cilomilast, tadalafil, and both drug combinations in the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
     BMC Cardiovasc Disord. 2025;25:591.
     PubMed    
     Abstract available
     
     

101. KAKAVANDI S, Zare I, Mirshafiei M, Zhang M, et al
     Antimicrobial PLGA-based micro/nanoparticles for nanomedicine of pulmonary diseases: From respiratory infections to pulmonary hypertension and fibrosis.
     Int J Pharm. 2025 Aug 7:126054. doi: 10.1016/j.ijpharm.2025.126054.
     PubMed    
     Abstract available
     
     

102. WANG FY, Yi J, Zhou LL, Tan JL, et al
     Unlocking the gut-lung axis: Feixin decoction as a novel modulator in hypoxic pulmonary hypertension.
     Phytomedicine. 2025;146:157118.
     PubMed    
     Abstract available
     
     

103. KUZEL TG, El-Kersh K
     Unilateral Absence of Pulmonary Artery Complicated With Severe Pulmonary Hypertension: Favorable Response to Parenteral Therapy.
     JACC Case Rep. 2025;30:104549.
     PubMed    
     Abstract available
     
     

104. LU GQ, Sun HY, Xu MY, Sun ZY, et al
     Salidroside ameliorates monocrotaline-induced pulmonary arterial hypertension in rats by modulating BKCa channels.
     Eur J Pharmacol. 2025;1004:177950.
     PubMed    
     Abstract available
     
     

105. LI Y, Zhang Y, Chen Y, Qiao Z, et al
     SIRT3 mediates Tubeimoside I's inhibition on pulmonary artery smooth muscle cell proliferation and oxidative stress in pulmonary arterial hypertension.
     Eur J Pharmacol. 2025 Jul 18:177938. doi: 10.1016/j.ejphar.2025.177938.
     PubMed    
     Abstract available
     
     

106. PALLOS LK, Matthey M, Hesse M, Fleischmann BK, et al
     A "second hit" mouse model for group 2 and 3 pulmonary hypertension: Combination of aortic banding and hypoxia exposure.
     Cardiovasc Res. 2025 Aug 26:cvaf147. doi: 10.1093.
     PubMed    
     
     
     

107. NOTO T, Ikeda N, Yamashita Y, Morimoto T, et al
     Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2.
     Catheter Cardiovasc Interv. 2025 Aug 26. doi: 10.1002/ccd.70130.
     PubMed    
     Abstract available
     
     

108. ZHAO P, Wang M, Liu Z, Zhang M, et al
     Advances in biomimetic nano delivery systems for pulmonary hypertension therapy.
     Acta Biomater. 2025 Aug 22:S1742-7061(25)00626.
     PubMed    
     Abstract available
     
     

109. TALON A, Sista RR
     Management of Patients with Pulmonary Hypertension: A Guide for Bedside Critical Care Nurses.
     Crit Care Nurs Clin North Am. 2025;37:421-431.
     PubMed    
     Abstract available
     
     

110. GRUBERT VAN IDERSTINE M, Kim S, Karur GR, Granton J, et al
     Utility of machine learning for predicting severe chronic thromboembolic pulmonary hypertension based on CT metrics in a surgical cohort.
     Eur Radiol. 2025 Aug 23. doi: 10.1007/s00330-025-11972.
     PubMed    
     Abstract available
     
     

111. OHNO K, Suwa K, Akita K, Sato R, et al
     Hemodynamics assessment using 4D flow CMR before and after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a retrospective observational study.
     BMC Cardiovasc Disord. 2025;25:621.
     PubMed    
     Abstract available
     
     

112. LANGENFELD TL, Sati M, Bocks ML, Agarwal AK, et al
     Large Patent Ductus Arteriosus in an Adult With Severe Pulmonary Hypertension and Polycythemia: PDA With Severe Pulmonary Hypertension.
     JACC Case Rep. 2025;30:104677.
     PubMed    
     Abstract available
     
     

113. WIEWIORA M, Kukulski L, Nowowiejska-Wiewiora A, Kuczmik W, et al
     Outcome predictors of general surgery procedures in patients with pulmonary hypertension.
     Kardiol Pol. 2025 Aug 22. doi: 10.33963/v.phj.108235.
     PubMed    
     
     
     

114. HOLCIK S, Hawayi L, Dussah N, Barrowman N, et al
     Risk Factors for Severe Respiratory Morbidity at 2 Years of Life in Children Born Extremely Preterm With Bronchopulmonary Dysplasia.
     Pediatr Pulmonol. 2025;60:e71258.
     PubMed    
     Abstract available
     
     

115. TAKANO R, Ueda J, Watanabe T, Tsukamoto Y, et al
     Development of severe pre-capillary pulmonary hypertension 7 years after heart transplant.
     JHLT Open. 2025;9:100274.
     PubMed    
     Abstract available
     
     

116. KANNA S K, Thirthashree K, Bhuvaneswari V, Parinita S, et al
     Platelet and Red Cell Indices: A Potential Biomarker for Predicting Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) Patients.
     Cureus. 2025;17:e88401.
     PubMed    
     Abstract available
     
     

117. WANG C, Chen M, Shi W, Xu Y, et al
     Survival analysis of infants with bronchopulmonary dysplasia-associated pulmonary hypertension: a single-center study in China.
     J Matern Fetal Neonatal Med. 2025;38:2546543.
     PubMed    
     Abstract available
     
     

118. SIAGIAN SN, Panjaitan EH, Nugroho PP
     Case Report: Non-reactive vasoreactivity testing in a patient with patent ductus arteriosus with pulmonary hypertension: is there still a way to turn things around?
     Front Cardiovasc Med. 2025;12:1569963.
     PubMed    
     Abstract available
     
     

119. WANG J, Zhang Y, Liu H, Liu L, et al
     Biomarkers in COPD-Associated PH/CCP: Circulating Molecules and Cell-Intrinsic Marker.
     Int J Chron Obstruct Pulmon Dis. 2025;20:2869-2883.
     PubMed    
     Abstract available
     
     

120. ELHAGE HASSAN M, Vinales J, Perkins S, Sandesara P, et al
     Pathogenesis, Diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension.
     Card Electrophysiol Clin. 2025;17:477-489.
     PubMed    
     Abstract available
     
     

121. NASRI A, Bashir R, Lakhter V
     Management of Complications of Balloon Pulmonary Angioplasty.
     Card Electrophysiol Clin. 2025;17:461-471.
     PubMed    
     Abstract available
     
     

122. SURESH MV, Aggarwal V, Raghavendran K
     The Intersection of Pulmonary Vascular Disease and Hypoxia-Inducible Factors.
     Card Electrophysiol Clin. 2025;17:429-438.
     PubMed    
     Abstract available
     
     

123. JAIN N, Perkins S, Maligireddy AR, Rosenfield K, et al
     Evolving Role and Clinical Evidence in the Global Practice of Balloon Pulmonary Angioplasty.
     Card Electrophysiol Clin. 2025;17:407-416.
     PubMed    
     Abstract available
     
     

124. TANNU M, Krasuski RA
     The Evolution of Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension.
     Card Electrophysiol Clin. 2025;17:369-379.
     PubMed    
     Abstract available
     
     

125. HOSOKAWA K, Yamasaki Y, Abe K
     Technical Considerations for Performing Safe and Effective Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension.
     Card Electrophysiol Clin. 2025;17:355-368.
     PubMed    
     Abstract available
     
     

126. ALENCAR AKN
     Coronary Compression in Pulmonary Hypertension: A Treatable Threat Hidden in Plain Sight.
     Arq Bras Cardiol. 2025;122:e20250352.
     PubMed    
     
     
     

127. JAVED R, Van Hasselt TJ, Rao N, Gowda H, et al
     Persistent Pulmonary Hypertension Among Infants Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy: A Systematic Review and Meta-Analysis.
     Ther Hypothermia Temp Manag. 2025 Aug 20. doi: 10.1177/21537658251370950.
     PubMed    
     Abstract available
     
     

128. STAFLER P, Schamroth N, Elizur A, Prais D, et al
     Left Main Bronchus Stenosis Leading to Bronchiectasis and Pulmonary Hypertension- Relieved by Stent Placement.
     Pediatr Pulmonol. 2025;60:e71251.
     PubMed    
     
     
     

129. FIORENTU G, Bernardinello N, De Michieli L, Marra MP, et al
     Pulmonary hypertension associated with sarcoidosis: current and future treatment landscape.
     Future Cardiol. 2025 Aug 19:1-3. doi: 10.1080/14796678.2025.2549173.
     PubMed    
     
     
     

130. OKEKE CC, Ojo A, Okere MO, Ebiliekwe OE, et al
     Pulmonary Hypertension Among Individuals Living With Hemoglobinopathies: A Systematic Review.
     Cureus. 2025;17:e88234.
     PubMed    
     Abstract available
     
     

131. HAYASHI K, Matsuo K, Aoki H
     Successful treat-and-repair strategy in a 5 year old with partial anomalous pulmonary venous connection, atrial septal defect, and severe pulmonary hypertension.
     Cardiol Young. 2025 Aug 19:1-3. doi: 10.1017/S1047951125101583.
     PubMed    
     Abstract available
     
     

132. WANG X, Li C, Wang S, Zhu Z, et al
     Utility of inhaled nitric oxide for pulmonary hypertension in cyanotic congenital heart disease: a cohort study with propensity score matching.
     Med Gas Res. 2026;16:93-97.
     PubMed    
     Abstract available
     
     

133. SONG Z, Ye T, Zhou Y, Yu F, et al
     TRPV2 Inhibition Prevents Right Ventricular Remodeling and Arrhythmia in Experimental Pulmonary Hypertension.
     FASEB J. 2025;39:e70949.
     PubMed    
     Abstract available
     
     

134. GREGORY ELLIOTT C
     FDA Approval of Epoprostenol to Treat Primary Pulmonary Hypertension.
     Pulm Circ. 2025;15:e70149.
     PubMed    
     
     
     

135. MORTAZAVI MOGHADDAM SG, Nosrati F, Mahdizadeh F, Kazemi T, et al
     Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients.
     Pulm Circ. 2025;15:e70153.
     PubMed    
     Abstract available
     
     

136. TORUN EG, Ozdemiroglu N, Cayhan V, Ece I, et al
     Life-saving stepwise management of pulmonary hypertension in an infant with Down syndrome presenting with a large patent ductus arteriosus and giant hepatic arteriovenous malformation.
     Cardiol Young. 2025 Aug 18:1-4. doi: 10.1017/S1047951125101662.
     PubMed    
     Abstract available
     
     

137. SYED M, Humbert M, Kovacs G, Sahay S, et al
     Overlapping pulmonary hypertension phenotypes in smokers: a call to action.
     Lancet Respir Med. 2025 Aug 14:S2213-2600(25)00259.
     PubMed    
     
     
     

138. CAJAS LJ, Recalde Reyes J, Correa JA, Carvajal W, et al
     Residence at high altitude as a risk factor for high probability of pulmonary hypertension in patients with systemic sclerosis: A case-control study.
     Reumatol Clin (Engl Ed). 2025;21:501899.
     PubMed    
     Abstract available
     
     

139. SHUAI J, He S, Wang Y, Zhen J, et al
     Dysregulated tryptophan metabolism and gut microbiota in chronic hypoxia-induced pulmonary hypertension rats.
     J Pharm Biomed Anal. 2025;266:117111.
     PubMed    
     Abstract available
     
     

140. ABOFREKHA B, Shadi M, Jdaidani J, Rojas-Marte GR, et al
     Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin.
     JACC Case Rep. 2025;30:104827.
     PubMed    
     Abstract available
     
     

141. RATRI AK, Saputri ON, Nugraha D, Nugraha RA, et al
     Echocardiographic correlation of right ventricular-Pulmonary artery coupling to exercise tolerance in congenital heart disease-associated pulmonary hypertension.
     Ann Pediatr Cardiol. 2025;18:26-32.
     PubMed    
     Abstract available
     
     

142. NOH M, Mitra A, Krebes L, Schmitz W, et al
     C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension.
     Commun Biol. 2025;8:1199.
     PubMed    
     Abstract available
     
     

143. CAI Z, Tu L, Tian S, Deng L, et al
     IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension.
     J Am Heart Assoc. 2025;14:e040896.
     PubMed    
     Abstract available
     
     

144. YE H, Zhang Y, Hu L, Feng Y, et al
     Novel and Highly Potent Therapeutic Agent, Trametes Robiniophila Murr (Huaier), Mitigates Pulmonary Vascular Remodeling in Rodents.
     J Am Heart Assoc. 2025;14:e041405.
     PubMed    
     Abstract available
     
     

145. LIU B, Zhaxi Q, Danzeng Z, Ci B, et al
     Elevated cytokine levels in patients with High-altitude pulmonary edema.
     Cytokine. 2025;194:157005.
     PubMed    
     Abstract available
     
     

146. CHEN P, Han Z, Ma Q
     Molecular mechanisms and therapeutic developments of BMPR2 in pulmonary arterial hypertension.
     Respir Investig. 2025;63:934-941.
     PubMed    
     Abstract available
     
     

147. NICOLEAU S, Valle YR, Tura-Ceide O, Armour CH, et al
     3D modelling of pulmonary arterial stenosis and endothelial dysfunction in CTEPH.
     Lab Chip. 2025;25:4369-4384.
     PubMed    
     Abstract available
     
     

148. CHEN Y, Zhang Q, Chen X, Xu Y, et al
     Long noncoding RNA FGD5-AS1-encoded micropeptides improve right heart functions of pulmonary arterial hypertension through restricting the synthesis of hyaluronic acid.
     Int J Biol Macromol. 2025;320.
     PubMed    
     Abstract available
     
     

149. LOPEZ-VELAZQUEZ R, Lopez-Moran S, Ramirez-Rivera A, Rubio-Infante N, et al
     Metabolic changes of peripheral blood mononuclear cells are related to the high cytokine levels in patients with pulmonary arterial hypertension.
     Life Sci. 2025;378:123852.
     PubMed    
     Abstract available
     
     

150. GOMAA DA, El-Haggar SM, El-Shanshory MR, El-Razaky O, et al
     Clinical Study to Evaluate the Possible Efficacy and Safety of L-Arginine in Children with Sickle Cell Disease and Increased Tricuspid Regurgitant Jet Velocity: a Randomized Controlled Trial.
     Paediatr Drugs. 2025;27:605-618.
     PubMed    
     Abstract available
     
     

151. KUCHERENKO MM, Kukucka M, Sang P, Hegemann N, et al
     Identification of pulmonary artery stiffening due to left heart disease by ultrasonography.
     Cardiovasc Res. 2025;121:1433-1447.
     PubMed    
     Abstract available
     
     

152. ISHII T, Uchida K, Hosokawa S, Ishizaki R, et al
     Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR).
     Am J Cardiol. 2025 Aug 6:S0002-9149(25)00437.
     PubMed    
     Abstract available
     
     

153. RAJA SG
     Editorial: Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan-Insights from the Japanese Association of Congenital Heart Disease Registry.
     Am J Cardiol. 2025 Aug 20:S0002-9149(25)00481.
     PubMed    
     
     
     

154. HAFEZ A, Ibrahim R, Pham HN, Rafie N, et al
     Clinical Outcomes Related to Patent Foramen Ovale in Group 1 Pulmonary Hypertension.
     Am J Cardiol. 2025 Aug 18:S0002-9149(25)00484.
     PubMed    
     
     
     

155. HAMADA T, Goda A, Yanagisawa Y, Takeuchi K, et al
     Differential Right Ventricular Afterload during Exercise in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
     Am J Physiol Heart Circ Physiol. 2025 Aug 4. doi: 10.1152/ajpheart.00477.2025.
     PubMed    
     Abstract available
     
     

156. DE BIE E, Correa-Jaque P, Jones R, Bogaard HJ, et al
     Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging Outcomes.
     Am J Respir Crit Care Med. 2025 Aug 11. doi: 10.1164/rccm.202412-2393.
     PubMed    
     Abstract available
     
     

157. MUKHERJEE M, Jani VP, Osgueritchian R, Mombeini H, et al
     Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Network.
     Chest. 2025;168:502-519.
     PubMed    
     Abstract available
     
     

158. CAO JY, Abdo RM, Wang N, Olsen N, et al
     Prognostic Value of Main Pulmonary Artery Diameter in Pulmonary Arterial Hypertension.
     Chest. 2025;168:476-487.
     PubMed    
     Abstract available
     
     

159. D'ALTO M, Vergara A, Orlando A, Naeije R, et al
     The fluid challenge for identification of pulmonary hypertension associated with left heart disease.
     Curr Opin Pulm Med. 2025;31:464-469.
     PubMed    
     Abstract available
     
     

160. VENTETUOLO CE, Sherman-Roe AE
     Sex differences in pulmonary (arterial) hypertension: does it matter?
     Curr Opin Pulm Med. 2025;31:411-428.
     PubMed    
     Abstract available
     
     

161. ZEDER K, Kovacs G
     Current hot topics in pulmonary hypertension.
     Curr Opin Pulm Med. 2025;31:409-410.
     PubMed    
     
     
     

162. JOHN T, Roschinsky T, Douschan P
     Echocardiographic evaluation of the pulmonary circulation and right ventricular functional unit during exercise and its clinical value.
     Curr Opin Pulm Med. 2025;31:456-463.
     PubMed    
     Abstract available
     
     

163. KAWASHIMA M, Ijiri N, Konoeda C, Toyokawa G, et al
     Extended use of central veno-arterial extracorporeal membrane oxygenation in lung transplantation for patients with pulmonary arterial hypertension.
     Eur J Cardiothorac Surg. 2025 Aug 4:ezaf256. doi: 10.1093.
     PubMed    
     Abstract available
     
     

164. HARBAUM L, Thenappan T
     Renal function dynamics in pulmonary hypertension trials: less than anticipated.
     Eur Respir J. 2025;66:2501042.
     PubMed    
     
     
     

165. SITBON O, Boucly A, Weatherald J, Antigny F, et al
     Drugs targeting novel pathways in pulmonary arterial hypertension.
     Eur Respir J. 2025;66:2401830.
     PubMed    
     Abstract available
     
     

166. BACCELLI A, Rinaldo RF, Haji G, Davies RJ, et al
     Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertension.
     Eur Respir J. 2025;66:2402026.
     PubMed    
     Abstract available
     
     

167. CORMICAN DS
     2025 ASE Guidelines on Echocardiographic Evaluation of the Right Heart with Focus on Pulmonary Hypertension: A Welcome and Necessary Update.
     J Cardiothorac Vasc Anesth. 2025 Jul 21:S1053-0770(25)00611.
     PubMed    
     
     
     

168. MOHAMA D, Worapongsatitaya P, Celestin B, Kazmirczak F, et al
     Comparison of the prognostic value of right atrial echocardiographic parameters in pulmonary arterial hypertension.
     J Heart Lung Transplant. 2025;44:1343-1347.
     PubMed    
     Abstract available
     
     

169. NAGARAJ S, Suhotliv A, Yakkali S, Steinberg K, et al
     Hemodynamic Effects of Sotatercept Administration in Pulmonary Hypertension- Insights from Remote Monitoring.
     J Heart Lung Transplant. 2025 Aug 4:S1053-2498(25)02174.
     PubMed    
     Abstract available
     
     

170. ANDARELLI JN, Issard J, Lacoste-Palasset T, Mallak I, et al
     Combined Multimodal Therapy in High-Risk Patients with Chronic Thromboembolic Pulmonary Hypertension and Both Distal and Proximal Lesions: A Prospective Observational Cohort Study.
     J Heart Lung Transplant. 2025 Aug 20:S1053-2498(25)02211.
     PubMed    
     Abstract available
     
     

171. SCHIPS TG, Kavalkovich KW, Yung LM, Ibrahim S, et al
     In vitro and in vivo characterization of wild type BMP9 and a non-osteogenic variant in models of pulmonary arterial hypertension.
     PLoS One. 2025;20:e0329089.
     PubMed    
     Abstract available